Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study
Authors
Keywords
Complications, Heart failure, Microalbuminuria, Multifactorial intervention, NT-proBNP, Type 2 diabetes
Journal
DIABETOLOGIA
Volume 61, Issue 8, Pages 1724-1733
Publisher
Springer Nature
Online
2018-05-31
DOI
10.1007/s00125-018-4642-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction
- (2017) Kevin S. Shah et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits
- (2017) Jens Oellgaard et al. KIDNEY INTERNATIONAL
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Corrections needed to 2016 ESC guideline and AHA scientific statement on heart failure
- (2017) Lars Rydén et al. Lancet Diabetes & Endocrinology
- Short term variation in NTproBNP after lifestyle intervention in severe obesity
- (2017) Debora Fedele et al. PLoS One
- Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
- (2016) Peter Gæde et al. DIABETOLOGIA
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial
- (2016) David Fitchett et al. EUROPEAN HEART JOURNAL
- SGLT2 inhibitors and heart failure — clinical implications
- (2016) Itamar Raz et al. Nature Reviews Cardiology
- No increased risk of heart failure with incretin-based drugs
- (2016) Dario Ummarino Nature Reviews Cardiology
- A Multicenter Observational Study of Incretin-based Drugs and Heart Failure
- (2016) Kristian B. Filion et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
- (2016) Ling Li et al. BMJ-British Medical Journal
- Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
- (2016) Ling Li et al. BMJ-British Medical Journal
- Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes
- (2015) Christopher J. Nolan et al. DIABETES
- The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
- (2015) David Preiss et al. EUROPEAN HEART JOURNAL
- Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy
- (2015) Richard E Gilbert et al. LANCET
- Obesity and natriuretic peptides, BNP and NT-proBNP: Mechanisms and diagnostic implications for heart failure
- (2014) Chaitanya Madamanchi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The microvascular effects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study
- (2014) A. M. Larghat et al. European Heart Journal-Cardiovascular Imaging
- Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
- (2014) John J V McMurray et al. Lancet Diabetes & Endocrinology
- Is the prognosis in patients with diabetes and heart failure a matter of unsatisfactory management? An observational study from the Swedish Heart Failure Registry
- (2013) Isabelle Johansson et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin Resistance and Heart Failure
- (2012) Annayya R. Aroor et al. Heart Failure Clinics
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
- (2008) Peter Gæde et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started